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Resumo 
A engenharia de tecidos é uma área emergente que permite o tratamento de várias 
doenças. Células estaminais mesenquimatosas podem ser usadas nestes tratamentos uma vez 
que têm a capacidade de se diferenciarem em diferentes tipos de células, incluindo 
osteoblastos, adipócitos e condrócitos. Contudo, pode ser necessária a sua expansão in vitro, 
previamente à sua utilização em aplicações clínicas, de modo a obter quantidades 
suficientes. Durante esse período, é necessário que as células estaminais mesenquimatosas se 
mantenham num estado indiferenciado. Podem para esse efeito ser usados hidrogéis como 
scaffolds devido à sua biocompatibilidade e ao seu alto conteúdo em água que promove a 
viabilidade celular. Pretende-se neste trabalho avaliar o potencial dos hidrogéis de ácido 
hialurónico e dextrino na proliferação das células estaminais mesenquimatosas, uma vez que, 
devido às suas propriedades químicas e mecânicas, estes hidrogéis imitam a matriz 
extracelular. Assim, estes hidrogéis foram avaliados de modo a determinar a duração do 
estado indiferenciado das células estaminais mesenquimatosas nestes biomateriais. 
Os hidrogéis de dextrino e de ácido hialurónico foram produzidos com diferentes tipos de 
ácido hialurónico e com diferentes rácios, tendo sido feita uma caraterização com base no 
grau de oxidação, tempo de gelificação e taxa de degradação. Foram realizados testes 
preliminares de viabilidade celular através do teste da resazurina e de atividade metabólica 
através do teste de MTT utilizando células MG-63. Por fim, os hidrogéis foram implantados 
subcutaneamente em ratos, tendo sido feita uma análise histológica de biocompatibilidade 
através da Norma ISO 10993. Os resultados mostraram que todos os hidrogéis tiveram um 
tempo de gelificação curto e que hidrogéis mistos com grandes percentagens de ácido 
hialurónico de alto peso molecular tinham a menor taxa de degradação. Testes de viabilidade 
resultaram em valores mais elevados para os hidrogéis de 100% dextrino e 100% ácido 
hialurónico. Hidrogéis de dextrino e ácido hialurónico foram considerados como ligeiramente 
irritantes ao longo de 15 dias. Futuramente deverão ser realizados mais testes. 
Este projeto resulta de uma parceria entre a Faculdade de Engenharia da Universidade do 
Porto, a Universidade do Minho e a empresa Biosckin. 
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Abstract 
Tissue engineering is an emergent field that allows the treatment of several diseases. 
Mesenchymal stem cells can be used in these treatments since they have the ability to 
differentiate into several types of cells, including osteoblasts, adipocytes and chondrocytes. 
However, cellular expansion in vitro may be needed before its use in clinical applications in 
order to obtain the required amount of cells. During that period mesenchymal stem cells need 
to maintain an undifferentiated state. Hydrogels can be used as scaffolds due to their 
biocompatibility and high water content that promotes cell viability. Hyaluronic acid and 
dextrin hydrogels can be used as a platform to proliferate mesenchymal stem cells, due to 
their chemical and mechanical properties that mimic the extracellular matrix. These 
hydrogels were evaluated to determine the duration of the undifferentiated state of 
mesenchymal stem cells in these biomaterials.  
Dextrin and hyaluronic acid hydrogels were produced with different types of hyaluronic 
acid and with different proportions. Their characterization was performed based on oxidation 
degree, gelation period and degradation rate. Preliminary viability tests were performed 
through a resazurin assay and a MTT assay, and using MG-63 cells. Finally, the hydrogels were 
implanted subcutaneously in mice and a histological analysis was performed through ISO 
10993 Standard to assess biocompatibility. Results showed a lower gelation time for all the 
hydrogels and low degradation rates for mixed hydrogels with high contents of high molecular 
weight hyaluronic acid. Viability assays revealed high values for 100% hyaluronic acid and 
100% dextrin hydrogels. Dextrin and hyaluronic acid hydrogels were found to be slight irritant 
during a 15 days period. Further testing should be performed. 
This project is a partnership between the Faculty of Engineering of University of Porto, 
University of Minho and Biosckin. 
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Chapter 1 
 
Introduction 
Tissue engineering is an emergent field for the treatment of several diseases as an 
alternative to allogenic and alloplastic transplants. This type of regenerative medicine can 
use cell transplantation and injection of growth factors or cells [1]. Stem cells can be used to 
treat wound healing, myocardial infarction, spinal cord injury or osteoarthritis, among other 
diseases, since they do not elicit an immunogenic reaction. According to the origin and 
potentiality of the cells, mammalian stem cells can be classified into two groups: embryonic 
stem cells and adult stem cells, which include mesenchymal stem cells (MSCs) [2]. MSCs are 
multipotent stem cells, able to differentiate into three main different cellular lineages: 
osteoblasts, adipocytes and chondrocytes [3]. The use of embryonic stem cells has several 
ethical controversies since their collection imply the destruction of a fetus. Therefore adult 
stem cells are emerging as a good alternative. However, cells must be propagated in vitro in 
order to obtain large numbers needed for biomedical applications [2]. 
Scaffolds play a major role in tissue engineering since they direct cellular processes based 
on its structural and biochemical properties. Different materials can be used according to the 
cell type, expected duration and microenvironment, and they determine several physical 
properties such as biocompatibility, biodegradability and mechanical stability [4]. The 
scaffold must also provide appropriate signals to direct cellular processes including cell 
adhesion and migration which can influence the survival of transplanted cells. The surface of 
the scaffolds can also be designed or functionalized with growth factors to control these 
processes [4]. Topographical patterns can also be introduced in order to orient cell growth, 
alter gene expression, and regulate the structure and the mechanical properties of the 
resulting tissue [4]. Several materials have been already investigated to produce scaffolds 
namely collagen, fibrin, alginate and hyaluronic acid (HA), for example [5]. 
 
1 Introduction 
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This project stems from the necessity to proliferate MSCs while preserving their 
undifferentiated state, until their differentiation is wanted for clinical use. Previous studies 
[6] reported that HA could maintain an undifferentiated state in human embryonic stem cells. 
Due to their physical and chemical characteristics, HA and dextrin (Dex) hydrogels will be 
produced in order to determine how long the undifferentiated state is maintained in this 
biomaterial. Physical and chemical tests will be performed to evaluate the cellular 
characteristics overtime. 
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Chapter 2 
 
State of the art 
This chapter presents the state of the art regarding the main subjects in this project: 
MSCs and hydrogels, including HA hydrogels and Dex hydrogels. 
 
2.1 – Mesenchymal stem cells 
Lately multipotent stem cells in adult tissue have received increased attention. MSCs 
have the ability to self-renewal and differentiate into several different types of cells namely 
osteocytes, adipocytes, chondrocytes, myocytes, cardiomyocytes and neurons (Figure 2.1) 
[2]. MSCs support hematopoiesis and increase the engraftment of hematopoietic stem cells 
after cotransplantation. Long-term culture of MSCs may result in senescence or spontaneous 
transformation [7]. 
 
 
Figure 2.1. Different types of cells differentiated from MSCs [8]. 
2 State of the art 
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MSCs are often identified by testing the differentiation potential of a culture into colony 
forming units which also indicates a proliferative capacity. In addition, the ability to adhere 
to tissue culture plastic and a fibroblast-like morphology are characteristics of MSCs. 
Different surface markers can be associated with these type of cells [9]. MSCs mainly express 
CD44s which is the standard form of CD44 whereas tumour cells are associated with the 
expression of several CD44 isoforms [10]. Astachov et al. [10] demonstrated that bone 
marrow-derived MSCs express toll-like receptors and this expression is upregulated in the 
inflammation zones.  
However, despite all the advantages of using MSCs in tissue engineering, the procedure to 
isolate this type of cells from the bone marrow is very invasive. In addition, the 
differentiation potential of bone marrow-derived MSCs is age-dependent so alternative 
sources such as umbilical cord blood and umbilical cord could be advantageous. In addition to 
the non-invasiveness of these sources, they have higher availability and potential for 
autologous cell-based therapy. Umbilical cord blood appears to be a less frequent source for 
MSCs than umbilical cord [7]. 
MSCs also have the ability to reduce allogeneic lymphocyte proliferation in vivo and in 
vitro which influences the rejection of infused cells. Recently, several studies reported that 
MSCs express different molecules involved in the inhibition of T-cell proliferation and 
dendritic cell differentiation, and other molecules responsible for the induction of T-cell 
anergy and regulatory T-cell expansion. Therefore, it was hypothesized that MSCs may have a 
role in inducing tolerance in the host immune system [3]. 
MSCs can be isolated from several sources: periosteum, trabecular bone, adipose tissue, 
synovium, skeletal muscle, deciduous teeth, amniotic fluid, umbilical cord blood, and 
umbilical cord, among others. The umbilical cord contains two arteries and one vein 
surrounded by mucoid connective tissue known as Wharton’s jelly (WJ) (Figure 2.2). MSCs can 
be isolated from either WJ or the umbilical cord vein, including perivascular regions. MSCs 
derived from the umbilical cord have no significant size differences and share the same 
surface markers as MSCs from other sources. Ishige et al. [7] successfully isolated MSCs from 
WJ, umbilical cord vein and arteries, and compared their proliferation and precursor 
potential. MSCs displayed similar fibroblast-like spindle-shaped morphology, with no 
significant differences relatively to the source. Over 90% of the cells exhibit positive surface 
antigenicity for CD13, CD29 (Integrin b1), CD73 (SH3), CD90 (Thy-1), CD105 (SH2; Endogrin), 
and HLA-ABC. 99% of the cells were negative for CD31, CD34, CD45, CD133, CD271, and HLA-
DR. This way, there was no significant difference in the surface antigenicity profiles of WJ, 
umbilical cord arteries and umbilical cord vein. GD2 antigen was expressed in all parts of 
cells as it can be seen in Figure 2.3 [7]. 
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Figure 2.2. Cross section of the umbilical cord showing the umbilical vessels [11]. 
 
   
Figure 2.3. GD2 antigen expression in MSCs from three different sources: WJ (A), umbilical cord vein (B) and 
umbilical cord arteries (C) [7]. 
 
At early passages, MSCs are reported to be small in size and spindle-like in morphology, 
and exhibit high proliferation rate and great differential potential. However, after a long 
period of expansion, MSCs become large and flatten, and lose their ability to self-renew and 
differentiate. At early passages MSCs also express a low level of lineage-differentiation genes 
such as Pax6, Gata4, Cdx2, Stella or Nestin for ectoderm, endoderm, trophoectoderm, 
germline or neural lineages, respectively. These are highly expressed after a long period of 
expansion [2]. 
Ishige et al. [7] evaluated the proliferation potential of MSCs from WJ and the umbilical 
vessels. Results from a 9 days assay indicated that WJ and umbilical cord arteries exhibited, 
after 3 days, a significantly higher proliferative potential than umbilical cord vein-derived 
cells (Figure 2.4) [7]. 
 
 
Figure 2.4. Doubling times of cell derived from WJ (black bars), umbilical cord vein (white bars) and umbilical 
cord arteries (hatched bars) [7]. 
A                                 B                                 C 
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Reactive oxygen species and other free radical emissions by cells and tissues are often 
considered as an indicator and a cause of aging in vitro and in vivo. However, in the case of 
MSCs, these reactive oxygen species are also involved in signalling, down-regulating 
proliferation and stimulating differentiation processes. In umbilical blood derived MSCs, 
superoxide radicals stimulate TGF-β1 which in turn stimulates colony forming units 
proliferation and osteogenic differentiation [9]. 
 
2.1.1 - Wharton’s jelly 
Umbilical cord is an extraembryonic formation that connects the placenta and fetus 
during pregnancy. It is covered by the umbilical epithelium, also known as amniotic 
epithelium, layered with cubic epithelial cells [3]. WJ was first described in 1656 by Thomas 
Wharton and is the primitive connective tissue of the umbilical cord, surrounding the 
umbilical vessels (Figure 2.5) [7]. It contains an abundant extracellular matrix (ECM) 
composed of sparse collagen fibers and an amorphous substance. The main function of WJ is 
to prevent torsion, compression and bending of the vessels, maintaining the blood flow 
between maternal and fetal circulations. WJ is rich in proteoglycans, such as HA, and two cell 
types: myofibroblasts and fibroblast-like cells. WJ expresses osteopontin, which is a regulator 
of hematopoietic progenitor cells and a major component of the hematopoietic stem cells’ 
niche along with HA. Myofibroblasts have ultrastructural characteristics of both fibroblasts 
and smooth muscle cells and play a role in fibrogenesis and contraction. Fibroblast-like cells 
constitute MSCs so they are multipotent, grow robustly in vitro, can be deep-frozen for long 
term storage, and maintain a morphology similar to fibroblasts during culture [3]. 
 
 
Figure 2.5. Cross-section of the umbilical cord showing WJ and the umbilical vessels [12]. 
 
Recently, more attention has been given to WJ as a potential new source of MSCs. 
However, the efficient isolation of cells that truly express MSCs characteristics has been 
controversial. Nanaev et al. [13] reported that cells close to the amniotic surface have higher 
capacity to retain the ability to proliferate whereas highly differentiated and non-
proliferating fibroblasts were located in closer proximity to the vessels. In other hand, Baksh 
et al. [14] showed that CD146-positive cells, including MSCs, were not distributed in WJ but 
Mesenchymal Stem Cells 2.1 
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in the perivascular region of the vein. The CD146 marker can be used to distinguish the 
multidifferentiation potential of different cell populations. WJ-derived cells show a 
phenotype closely resembling that of MSCs derived from bone marrow. They express CD10, 
CD13, CD29, CD44, CD49e, CD73, CD90, CD105, CD166 and HLA class I. In addition, similar to 
bone marrow-derived MSCs, WJ-derived cells lack expression of hematopoietic markers such 
as CD34 and CD45 [3]. Ishige et al. [7] reported that cells derived from WJ were unable of 
undergoing osteogenic differentiation until day 49 of culture, despite the detection of 
osteopontin transcripts. Alkaline phosphatase activity also appeared defective in WJ and in 
umbilical cord vein cells. However, relatively high alkaline phosphatase activity was present 
in umbilical cord arteries-derived cells, even in non induction medium. This suggests that 
cells derived from umbilical cord arteries may retain characteristics of the arterial wall since 
alkaline phosphatase activity is specific to arterial segments but not to venous segments. In 
addition, Mitchell et al. [15] reported that pre-chondrocytes were present in explants WJ 
cultures. Ishige et al. [7] differentiated the cells derived from WJ into chondrocytes and 
observed that the cell populations derived from WJ and the umbilical vessels appeared to 
consist of different proportions of multipotent stem cells, even though no major differences 
in antigens profiles was found [7]. Cells derived from these sources exhibited strong positive 
staining by toluidine blue for ECM, suggesting that new ECM was induced by chondrogenic 
differentiation (Figure 2.6). WJ-derived cells can be differentiated into chondrocytes-like 
cells if cultured in a medium supplemented with ascorbic acid, transferrin, dexamethasone, 
retinoic acid and TGF-β3 for up to 46 days [3]. In their experiments, Ishige et al. [7] could 
not demonstrate the differentiation ability derived from a single cell maybe because it could 
already enter in a senescence state during the explants migration or the environmental 
culture conditions were not appropriate for expansion. However, the investigators claim that 
umbilical cord-derived cells with the typical phenotypes for MSCs might be equivalent to 
bone marrow-derived cells. MSCs can also differentiate in neuron-like cells and 
cardiomyocytes [7]. 
 
 
Figure 2.6. Chondrogenic differentiation potential of cells derived from WJ (UCWJ), umbilical cord vein (UCV) 
and umbilical cord arteries (UCA). Results from toluidine blue staining in cells induced with chondrogenic 
differentiation medium with different magnification:  x10 (a) and x40 (b). Bar = 1mm [7]. 
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Iacono et al. [3] reported that WJ-derived cells express mesodermal markers (vimentim 
and α-smooth muscle actin), endodermal markers (Gata-4, Gata-5, Gata-6 and HNF4-α), and 
neuro-ectodermal markers (nestin, neuron specific enolase and glial fibrillary acid protein) 
which indicates that these cells can differentiate towards different mature cell types derived 
from all three germ layers. WJ-derived cells can be cultured in a medium supplemented with 
factors inducing osteogenic differentiation. Consequently, they can express osteonectin, 
osteopontin, periostin and runx2 genes and proteins. The differentiation into an osteoblast 
can be confirmed also by histological stains such as Alizarin Red and Von Kossa which allow 
the visualization of calcium deposits in the ECM. In addition, this type of cells can be induced 
with adipogenic induction medium and develop lipid vacuoles that can be stained using Oil 
Red O. They also express proteins namely adiponectin, leptin and PPAR [3]. 
Seeding density is an important factor in the presence of chondrogenic medium and 
influences the chondrogenic potential. Wang et al. [16] cultured MSCs from WJ in a 
chondrogenic medium within PGA scaffolds for one month at different seeding density: 5, 25, 
and 50 million cells/ml. Higher density groups showed more glucosaminoglycans (GAGs) and 
collagen type I and II than in a lower density group. Mechanical integrity was also higher in 
the higher density group. This indicates the potential for chondrogenic differentiation and 
the importance of higher seeding density in order to promote biosynthesis and mechanical 
integrity for a possible application in fibrocartilage tissue engineering [3]. 
 
2.1.2 – Maintenance of the undifferentiated state of mesenchymal stem cells 
One limitation to the use of MSCs in clinical applications is their tendency to lose potency 
for proliferation and differentiation when cultured in vitro which is influenced by donor age, 
plating density, serum composition, and passage time. This way, methods to maintain the 
long term multipotency of these cells would significantly improve their use in clinical settings 
[17]. 
MSCs must balance self-renewal and differentiation, and complex regulatory mechanisms 
are required to maintain stem cells undifferentiated and to control their subsequent 
differentiation and proliferation. It has been reported that the mesenchymal phenotype can 
be maintained under optimal culture conditions. Toyoda et al. [18] reported that the 
inhibition of the p16/Rb pathway is sufficient to extend the life span of cells in cultures of 
bone marrow-derived cells. This pathway leads to senescence and can be inhibited by 
inducing the human papillomavirus type 16 E7 gene, allowing the long term cultivation of 
bone marrow-derived cells. MSCs can also have their life span extended via retroviral 
transduction of human telomerase reverse transcriptase. In this process, cell characteristics 
remain unaffected, including the surface markers and the growth factor reactivities of 
transduced cells. Toyoda et al. [18] also reported that excessive stimulation by growth 
factors can be a cell senescence inducer so this factor needs to be taken into account. 
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Stem cells are reported to survive in a hypoxic environment and this condition influences 
the maintenance of multipotency and extension of survival. However, the degree and 
duration of hypoxia described in the literature vary greatly and may result in opposite effects 
on the proliferation and differentiation capacities of MSCs [19]. Grayson et al. [20] studied 
the long term effect of human MSCs cultured under low O2 tension (2% O2) and showed 
improved survival and increase in adipocytic and osteogenic differentiation capacity. In 
another study, Basciano et al. [19] compared cultured human MSCs derived from bone 
marrow in normoxia (21% O2) or hypoxia (5% O2) for up to passage 3. They observed that cells 
under low O2 tension were more undifferentiated than cells cultured in normoxia. In addition, 
hypoxia inhibited the expression of genes involved in DNA replication and cell division at 
passage 0. However, in later passages, cells expanded faster. In this study, cultured cells 
displayed a typical MSC profile with stable phenotype overtime and no significant phenotypic 
differences between hypoxic and normoxic conditions were found. Hypoxia also inhibited the 
biosynthesis of mitochondria in 50% to 75% of cells. The investigators also differentiated the 
MSCs in both conditions and observed that hypoxic cells were more prone to osteogenic 
differentiation than normoxic cells and that the expression of alkaline phosphatase was 
stronger in hypoxic MSCs. This study reflects the capacity of hematopoietic and stromal stem 
cells to adapt to hypoxia in culture. Hypoxic MSCs are also more adhesive [19].  
MSCs express Oct4 or Nanog, which can be increased under specific conditions such as 
serum deprivation. These are pluripotency genes that constitute the core regulatory network 
that suppresses differentiation-associated genes, thereby maintaining the pluripotency of the 
cells. Expression of these genes is restricted to plutipotent cells and is downregulated upon 
differentiation. Chih-Chien et al. [2] reported that Oct4 and Nanog levels were higher in early 
passages, as expected, and in hypoxic cultures. In addition, the protein levels of Oct4, the 
isoform associated with pluripotency, were maintained over long-term cultures in hypoxia. 
Knockdown of Oct4 or Nanog induced an increase in the expression of Pax, Gata4, Gata6, 
Sox17, and FoxA2 at early passages in MSCs cultured in hypoxic conditions which indicates 
spontaneous differentiation. These results suggest that Oct4 and Nanog prevent spontaneous 
differentiation in MSCs. In addition, the overexpression of Oct4 and Nanog in MSCs enhances 
the proliferation rate and differentiation potential while inhibiting spontaneous 
differentiation during expansion under normal culture conditions [2].  
In another study, Zhang et al. [17] used microcontact printing of alkanethiolates on gold 
as a model system for culturing MSCs in patterns. Results showed that by restricting cell 
spreading, the MSC phenotype was maintained, with higher levels of stem cell markers, even 
after the removal of the patterns. The differentiation potential was not affected. When 
confined to the microislands so created, MSCs did not divide because DNA synthesis was 
restricted. MSCs are also characterized by positive expression of markers such as CD31, CD44, 
CD90, Stro-1, endoglin, CD106, and CD166. In this study, Stro-1 and endoglin were observed 
to have higher expression during early passages compared to senescent passages and Stro-1 
has been shown to be downregulated in prolonged cultures. When MSCs are confined to small 
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islands express higher levels of endoglin and Stro-1 compared to cells cultured on non-
patterned surfaces, even after the cells are removed from the islands after a week and 
cultured on tissue culture plastic for up to 16 days [17].  
Gerecht et al. [21] also reported the maintenance of the undifferentiated state of human 
embryonic stem cells in HA hydrogels in the presence of conditioned medium from mouse 
embryonic fibroblast feeder layers until soluble factors are introduced to direct cell 
differentiation. During development, cellular interactions with HA are mediated by CD44 
which is highly expressed in vitro by human embryonic stem cells [6]. Since MSCs also express 
CD44, it may be possible for HA hydrogels to control their undifferentiated state [3]. 
  
The main requirement when culturing MSCs is to recreate the specific native tissue/organ 
milieu of the cell’s origin; hence the choice of HA and Dex hydrogels, which are going to be 
used in this project. 
 
2.1.3 – MG-63 cells 
MSCs differentiate in several types of cells, including cells from the osteogenic lineage. In 
many in vitro studies of the interactions between cells and biomaterials, immortalized cell 
lines have been used instead of primary cells like MSCs due to mainly practical reasons: 
immortalized cell lines are easier to acquire than primary cells and grow in vitro for an 
indefinite number of passages [21]. To test the differentiation profile in biomaterials, human 
osteoblast-like cell line MG-63 can be used as cellular prototype since they have the capacity 
to undergo osteoblastic differentiation in response to an osteogenic environment [21][22]. 
This cell line was originally isolated from a human osteosarcoma (the most common primary 
solid tumour of bone in children and young adults) and has been well characterized and 
largely used in biocompatibility tests [23].  
MG-63 cells produce collagen type I and express ALP activity which is further enhanced by 
dihydroxyvitamin D3. This also enhances the production of osteocalcin and other markers of 
osteoblast function. The interaction between dihydroxyvitamin D3 and TGF-β appear to 
induce differentiation of MG-63 cells into the ECM maturation stage without continued 
differentiation into the mineralized state, presenting a similar behaviour as human explants 
bone cells [24]. Unlike osteoblasts, MG-63 cells do not vary their size depending on cell 
density. They are oval to spindle-shaped, without branching processes [25]. 
Comparing MSCs and MG-63 cells, they both express exogenous p75NTR protein which is an 
important neuronal signalling molecule that interacts with numerous ligands and coreceptors, 
promoting cell proliferation and osteoblast differentiation [26]. MG-63 cell adhesion is 
significantly inhibited by function-blocking antibodies against the αv and α5 integrin subunits 
that are involved in binding to fibronectin. However, MSCs use αv-containing integrins to 
adhere to fibronectin [21]. Regarding surface markers, both MSCs and MG-63 cells highly 
express CD90 and CD44 [27]. 
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2.2 – Hydrogels in Tissue Engineering 
 
Tissue engineering takes advantage of scaffolds to direct cellular processes, hence the 
choice of its structural and biochemical properties is decisive. Hydrogels have been used in 
clinical applications, such as drug delivery systems, tissue replacements, immobilization of 
proteins and cells, due to their high water content that promotes cellular viability since they 
are mechanically and structurally similar to the ECM of most biological tissues. In addition, 
hydrogels are highly customizable and biocompatible [28]. However, their tunable properties 
can influence the final results and are not always reported. This includes the hydrogel 
chemistry, the type of polymerization and the total polymer content, which will influence 
how transplanted cells react to hydrogel encapsulation. Hydrogel biocompatibility is 
improved when its mechanical properties are matched those of the host tissue [29][30]. 
Injectable hydrogels can be maintained in the liquid state before injection and harden 
after transplantation in vivo. The hydrogel allows the filling of irregular defects, decreases 
the risk of implant migration and minimizes surgical defect to the size of a needle. In 
addition, the hydrogel can be incorporated with therapeutic factors and cells [31]. Hydrogels 
can also be stimuli-sensitive and respond to pH, temperature, electric field, glucose and 
antigens, among others. This way the hydrogel can have a controlled drug release due to 
volume changes [30]. 
Hydrogels are composed of hydrophilic polymer chains and can be fabricated using 
natural or synthetic materials namely HA, collagen and Dex.  
  
2.2.1 - Hyaluronic Acid 
HA (Figure 2.7) is a linear polysaccharide consisting of alternating 1,4-linked units of 1,3-
linked glucoronic acid and N-acetylglucosamine. This oligosaccharide adopts three-
dimensional structures in solution with extensive intramolecular hydrogen bonding, 
restricting the conformational flexibility of the polymer chains and inducing distinctive 
secondary and tertiary interactions [32]. HA has several desired properties that can be used 
for application as a biomaterial in tissue engineering. It is a major intracellular component of 
the umbilical cord, synovial fluid of joints, cartilage and vitreous fluid of the eye, among 
others, and is synthesized at the inner wall of the plasma membrane by cells of mesenchymal 
origin [4][30][33]. HA can be synthesized by three types of HA synthase (HAS1, HAS2 an HAS3) 
which are located in the cell membrane and, after production, is immediately extruded out 
of the cell into the ECM where it interacts to provide mechanical support [33].  
GAGs have a unique water binding ability due to the highly negative charge on the 
molecular chain [31]. This way, they can absorb large amounts of water and expand up to 
1000 times in volume, forming a loose hydrated network. Due to this fact, HA acts as a space 
filler, lubricant, and osmotic buffer in the native ECM. This hydrated HA network controls the 
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transport of water, restricts the movement of pathogens, plasma proteins and proteases, and 
maintains the viscoelasticity of the connective tissues [33]. 
 
 
Figure 2.7. Basic chemical structure of HA [33]. 
 
HA exists as a high molecular weight (MW) polymer and forms the backbone of 
proteoglycans in the ECM. It differs from synthetic polymers such as polyethylene glycol (PEG) 
since it is biologically active, playing an important role in structure, lubrication, cell 
differentiation, cell migration, cell proliferation, and cell growth since cellular interactions 
occur through cell surface receptors such as CD44, RHAMM and ICAM-I [1][33]. HA interacts 
with these surface receptors to activate various signalling pathways such as c-Src, Ras and 
mitogen-activated protein kinases (Figure 2.8) that direct cell functions [33]. It also 
influences biological processes including morphogenesis, wound repair, and metastasis [1][4]. 
Inflammation can also be mediated by HA due to its ability to inhibit macrophage migration 
and aggregation, and to prevent the immune complex from adhering to polymorphonuclear 
cells. HA influences wound healing since it usually increases at scarless fetal wounds due to 
the reduced expression of proinflammatory cytokines (IL-1 and TNF-α) which are responsible 
for the down regulation of HA synthesis. HA expedites the delivery of solutes and nutrients 
due to its high water absorption capacity and its ability to stimulate inflammatory signals for 
wound healing. HA also improves cell migration and proliferation which are essential for this 
process [33]. 
HA degrades in the presence of hyaluronidases and free radicals [30]. Hyaluronidase 
degradation of HA results in the cleavage of internal α-N-acetyl-D-glucosaminidic linkages, 
producing fragments with N-acetylglucosamine at the reducing terminus and glucuronic acid 
at the nonreducing end. The networks decrease in size during degradation and exposure to 
hyaluronidase due to surface erosion, and attraction between positively charged groups 
produced during degradation and the negatively charged carboxylic acid groups of HA [5]. 
The degraded species are internalized by cells and degraded in lysossomes or transferred to 
the circulation and then cleared by the drainage systems such as liver, lymph nodes or 
kidneys. The half-lives of HA in biological tissues range from minutes in the blood to hours or 
days in skin and joints. However, this material is attractive for the fabrication of scaffolds 
since it is biocompatible, biodegradable, bioactive, non-immunogenic and non-thrombogenic. 
In physiological solutions, HA assumes an expanded random coil structure [33]. In addition, 
the rate of degradation depends on the hydrophobicity of the crosslinker used: increased 
hydrophobicity results in less degradable hydrogels [32]. HA degradation products appear to 
Hydrogels in Tissue Engineering 2.2 
13 
 
have different biological functions from the native high MW polymer. Oligosaccharides of less 
than 20 disaccharides have been shown to be angiogenic and low and intermediate MW HA 
stimulate gene expression in macrophages, endothelial cells, eosinophils and certain 
epithelial cells. In addition, HA degradation products contribute to scar formation, especially 
if hyaluronidase is added to stimulate degradation. However, high MW HA promotes cell 
quiescence and supports tissue integrity. Under physiologic conditions, HA exists as a high MW 
polymer but following tissue injury, HA fragments of lower MW accumulate [34]. 
 
 
Figure 2.8. Signaling mechanism of HA [34]. 
 
HA is highly expressed in tumours and is a main component of the microenvironment of 
cancer cells. In addition, on the cell surface this GAG directs the metastasis of tumour cells 
by altering its biological activity and triggering the TGF-β, Rho GTPase, and FAK pathways 
through interactions with cancer cells surface receptors. In tumour sites, HA facilitates 
migration of invasive tumours through the expansion upon hydration and interaction of HA 
through specific cell surface receptors. HA oligomers encourage angiogenesis and induce 
inflammatory cytokine production that activates signalling mechanisms for cancer 
progression. This way, HA and hyaluronidase levels influence tumour progression and 
angiogenesis. In addition, HA coating around tumour cells protects them against the immune 
system, as explained previously [33]. 
It was observed that cellular interactions between chondrocytes and HA help the 
organization of the ECM of cartilage and retain proteoglycans within the cartilage. HA also 
stimulates the chondrogenic differentiation of MSCs and the proteoglycan production through 
its interaction with the chondrocytes [33]. 
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For clinical applications and cosmetics, high MW HA (usually more than 1MDa) can be 
produced in large quantities with high purity by bacterial fermentation. Low MW HA can also 
be produced by γ irradiation or enzymatic degradation. Chemoenzymatic processes can be 
used to control molecular size distribution [33]. 
Soluble HA has been used in several clinical applications but native HA is not useful as a 
biomaterial due to its poor mechanical properties; also, rapid degradation and clearance in 
vivo limit its applications. In order to improve its mechanical properties HA can be combined 
with other materials such as collagen, be chemically modified or even crosslinked to form 
hydrogel. Chemical modification of HA usually involves the carboxylic acid and/or the alcohol 
groups of its backbone. The carboxylic acid groups can be modified by esterification and 
crosslinked via dihydrazide, dialdehyde or disulfide crosslinkers [4]. Comparing crosslinked HA 
with the native one, the first exhibit more robust mechanical properties and is less 
susceptible to enzymatic degradation. Covalent crosslinking of native HA can require toxic 
reagents (such as EDC) and harsh conditions that are not suitable for cell and protein 
encapsulation. So, for tissue engineering applications, the synthesis of HA hydrogels should be 
chemo-selective and occur under physiological conditions without creating any toxic by-
products [33]. Prestwich et al. [32] produced HA hydrogels using adipic dihydrazide (ADH) as 
a crosslinking agent (Figure 2.9) and described them as possessing good biocompatibility. The 
hydrazide moieties are nucleophilic at low pH (3.0 to 4.75), leading to efficient coupling of 
the hydrazide to the carboxylic acids of the glucuronic acid units of HA. Linkers containing 
disulfide bridges can be introduced into the gel formation process to incorporate a way to 
unlink the gel. This type of gels can be reduced with thiols, hydrides, and phosphines back to 
sol form [32]. 
 
 
Figure 2.9. Functionalization and crosslinking of HA with ADH [32]. 
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To regulate cellular interactions with hydrogels, cell adhesion sites can be introduced to 
HA by modification with the integrin binding peptide Arginine-Glycine-Aspartic Acid (RGD) or 
by coating them with adhesion proteins including collagen, laminin and fibronectin. 
Irradiation with ultraviolet light can also induce surface modifications that promote cell 
adhesion [4]. In another study, Burdick et al. [5] used HA with MW ranging from 50 to 1100 
kDa modified with methacrylic anhydride and photopolymerized into networks and observed 
compressive moduli up to 100 kPa, swelling ratio from 8 to 42, and degradation times from 
less than 1 day up to 38 days in the presence of 100 U/mol of hyaluronidase, with macromer 
concentrations from 2 to 20 wt% (Figure 2.10). Biological functionalities can be incorporated 
into HA gels through the coupling of cytokines and therapeutic drugs, enabling the 
encapsulation of cells during gelation. The gelation kinetic should be fast enough to allow in 
situ cell encapsulation for the fabrication of 3D cell/gel constructs or in vivo hydrogel 
formation in a minimally invasive injectable manner [33]. 
 
 
  
   Figure 2.10. Mechanical properties of HA hydrogels produced. A. Representative stress versus strain plots 
fabricated from 10 (solid) and 5 (dotted) wt% macromers (50 kDa methacrylated HA). B. Compressive modulus for 
various HA networks at equilibrium swelling. C. Equilibrium volumetric swelling ratio for photocrosslinked HA 
networks with variations in macromer MW and concentration. D. Time for complete degradation of HA hydrogels in 
100 U hyaluronidase/ml of PBS, where the hyaluronidase was replenished every other day throughout degradation. 
The compressive moduli and the swelling ratios are statistically different between the different macromer 
concentrations for each MW methacrylated HA [5]. 
 
A                                                                    B 
 
 
 
 
 
 
 
 
 
C                                                                     D 
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Aurand et al. [29] studied the polymerization and degradation rates of hydrogels 
produced with different concentrations of HA and PEG and results showed that 
polymerization time decreased as HA and PEG concentrations both increased (Figure 2.11.A). 
Results also showed that hydrogels with greater concentrations of both materials had slower 
degradation. In addition, at higher PEG contents (1.8% to 3.0%), degradation rate was 
dependent on the HA content of the hydrogel (Figure 2.11.B) and changes in compressive 
modulus were driven mainly by the HA concentration [29]. 
Traditional HA-based hydrogels are macroscopic networks consisting of randomly 
interconnected HA chains. Drug molecules encapsulated in the network without any covalent 
linkage are released rapidly due to relatively large pore size. HA hydrogels with micro or 
nanopores can also be produced. These exhibit tunable size, large surface area, abundant 
interior space and addressable functional groups, allowing the encapsulation of active 
compound and control of their release. The water-filled interior also prevents severe 
aggregation of the drug and is suitable for the physical association and covalent conjugation 
of therapeutic agents. In addition, these HA hydrogels are unable to induce cells to 
regenerate architecturally complex healthy tissue [33]. 
 
 
Figure 2.11. Physical properties of the hydrogel. Polymerization and degradation rates were determined in 
vitro. A. Polymerization rate measured in minutes. B. Degradation rate of hydrogels submerged in hyaluronidase 
solution measured in days [29]. 
 
HA-mediated signals are transmitted through cell surface receptors that are also 
expressed in MSCs: CD44, RHAMM (receptor for HA mediated motility) and the toll-like 
receptor 4. CD44 is the main receptor for HA and is one of the specific markers for MSCs. 
CD44 is a cell surface transmembrane protein that mediates cellular interactions and cell-
ECM interactions, and is expressed by several cells and tissues. It regulates different 
biological functions such as cell-cell adhesion, pericellular matrix assembly, cell migration, 
HA endocytosis and tumour cell metastasis. Although CD44 proteins are encoded by a single 
gene, cells that display CD44 express some heterogenic isoforms of this receptor due to 
posttranslational modifications and to alternative splicing of ten variant exons in the cell 
membrane vicinity at the proximal region of the extracellular domain. The cytoplasmic tail of 
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CD44 does not contain actin-binding sites, and its interaction with the cytoskeleton is 
mediated by cytoskeleton-associated proteins such as merlin and ankyrin among others. HA 
also influences the integrity of the cytoskeletal structures since the cytoplasmatic domain of 
CD44 is required for HA binding and its internalization. The affinity of CD44 to this GAG 
requires a very specific glycosylation pattern and helical folding of the HA-binding domain of 
CD44 [10]. 
RHAMM is another HA receptor that is critical for cell motility and focal adhesion 
turnover. Similarly to CD44, RHAMM also has multiple isoforms. It is located at the cell 
membrane and has no transmembrane or cytoplasmic domains. However, Assman et al. [35] 
reported that it is present in the cytoplasm where RHAMM interacts with microtubules and 
actin filaments. This receptor is activated during cell migration and its inhibition during 
embryogenesis causes loss of pluripotency and cell viability in human embryonic stem cells. 
Further experiments revealed that in CD44 knockout mice, the RHAMM gene compensates for 
the loss of CD44 by supporting up-regulating genes associated with CD44. In addition, toll-like 
receptors for HA are involved in the signalling of bone marrow-derived MSCs and are used to 
detect inflammation and initiate host defence response mechanisms [9]. 
 
2.2.2 - Dextrin 
Dex (Figure 2.12) is a polymer composed of α-(1→4) D-glucose units produced by partial 
hydrolysis of starch using acids, enzymes or a combination of both. This material is used in 
several applications including adhesives, and in food industry and textiles [37]. Dex is already 
used clinically as a peritoneal dialysis solution [38][39]. In addition, due to its 
biocompatibility and biodegradability, Dex hydrogels can be used in tissue engineering. 
Systems based on linear Dex have been found to promote cellular growth [37].  
 
This biocompatible polymer can be hydrolyzed enzymatically by α-amylase which is 
responsible for in vivo degradation of Dex [28][39]. In Dex hydrogels, degradation occurs 
mainly by bulk erosion and it is characterized by nonlinear degradation profile with an 
increasing pore size. This variation affects the swelling of the hydrogel, the diffusion of 
molecules, and the delivery of cells when the hydrogel is used for cell encapsulation [28]. 
 
 
Figure 2.12. Basic chemical structure of Dex [36]. 
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The production of starch-based hydrogels can include one or two-step free radical graft 
polymerization of hydrophilic vinyl monomers in the presence of a crosslinker. However, this 
technique presents some disadvantages such as the use of catalysts which are difficult to 
remove from the reaction mixture and could significantly increase the toxicity of the material 
[36]. 
Previous studies evaluated cell spreading of cells growing on starch-based hydrogels and 
revealed differences in cell morphology. Cells appeared round and clustered but viable when 
grown in hydrogels [40]. Moreira et al. [38] developed a strategy to functionalize a Dex-based 
hydrogel using a RGD-sequence and results with fibroblasts showed that in this condition the 
cells are uniformly distributed while exhibiting the characteristic fibroblast morphology 
(Figure 2.13). These results indicate that cell spreading occurred. Moreira et al. [38] also 
performed MTS assays to analyse cell adhesion and results (Figure 2.14) indicate that Dex 
hydrogels have a 50% adherent cells. Moreira et al. [38] also evaluated cell proliferation and 
reported that there is a moderate cell growth on non-activated hydrogels, and that the 
presence of a starch-binding molecule and a RGD sequence do not lead to a significant 
increase in the proliferation rate, despite its effect on cell morphology [38]. 
 
 
Figure 2.13. Microscopic analysis of the fibroblasts cultivated on Dex hydrogels without recombinant proteins, 
coated with a starch-binding molecule (SBM), and coated with a starch-binding molecule and a RGD sequence 
(RGDSBM) with different incubation times [38]. 
 
Dex hydrogels can be obtained by crosslinking following oxidation. The oxidized dextrin is 
characterized by their oxidation degree which consists on the quantification of aldehyde 
groups. The oxidation reaction is characterized by the specific cleavage of the C2-C3 linkage 
of glucopyranoside rings, yielding two aldehyde groups per glucose unit. The degree of 
oxidation (DO) can be easily controlled by the relative quantity of sodium periodate used, 
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yielding free aldehyde groups to create covalent linkages with reticulating molecules or 
cellular adhesion binding peptides. Dex solutions can only be produced with concentrations 
less than 30% (w/v). Above that value, the solution is extremely viscous and very difficult to 
homogenize. This way, this concentration is considered the threshold of Dex solubility in 
phosphate buffer pH 6.0 [28]. 
 
 
Figure 2.14. MTS analysis using Dex hydrogels without recombinant proteins, coated with a starch-binding 
molecule (SBM), and coated with a starch-binding molecule and a RGD sequence (RGDSBM) [38]. 
 
The DO and the concentration ADH, which is a reticulating molecule, influence the 
gelation periods, as it can be seen in Table 2.1. The DO was calculated as the molar ratio of 
sodium periodate per initial glucose unit in Dex. The ADH concentration was calculated in 
molar base, taking into account the number of glucose residues in the original Dex. Results 
show that gelation times decrease with increasing DO. It is reported that a DO above 40% 
yield very viscous solutions that react promptly with ADH, preventing good homogenization 
and resulting in mat and brittle hydrogels. This way, 40% is the desired DO for Dex hydrogels. 
In addition, an increased concentration of ADH results in a proportionally higher compressive 
modulus for cross-linked Dex hydrogels as it can be observed in Figure 2.15 [28]. 
 
Table 2.1 - Gelation periods estimated for Dex hydrogels with different ADH concentrations. Gelation times 
correspond to more than 1h (+++), less than 30min (++) or less than 1min (+) [28]. 
Degree of oxidation (%) 
ADH (%) 
5 15 30 
25 
+ + + 
32.5 
++ (~30 min) ++ (~10 min) ++ (~15 min) 
40 
++ (~2 min) +++ +++ 
50 
+++ +++ +++ 
 
Molinos et al. [28] also characterized biocompatibility for Dex hydrogels and it was 
observed that the products of the hydrogels degradation can be potentially cytotoxic and 
cellular death is observed when the degradation products of Dex are in direct contact with 
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cells. This is due to mechanical pressure or decreased oxygenation and nutrient diffusion 
caused by the products sedimentation. However, since there is a rapid reabsorption and 
excretion in vivo, cytotoxicity decreases for in vivo assays [28]. 
 
 
Figure 2.15. Compressive modulus of crosslinked Dex hydrogels as a function of ADH concentration (A) and DO 
(B) of Dex [28]. 
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Chapter 3 
 
Materials and Methods 
All reagents used were purchased from Sigma-Aldrich, unless stated otherwise. Tackidex 
Dex was obtained from Roquette and Hyasis® Link Hyaluronic Acid (CL-HA) (0.7 - 1 MDa) was 
obtained from Novozymes Biopharma. Hylumed high MW HA (0.8 – 2 MDa) was obtained from 
Genzyme Corporation and low MW HA (<10 kDa) was obtained from Lifecore Biomedical. 
Oxidized Dex was prepared according to Molinos et al. [28] and the three types of HA 
followed the same protocol. 
 
3.1 – Production of hyaluronic acid and dextrin hydrogels 
 
3.1.1 – Dextrin preparation 
Aqueous solutions of Dex (2% w/v) were prepared. Dex was oxidized with sodium m-
periodate solution at room temperature, in the dark and with stirring for 20h, in order to 
obtain a theoretical DO of 40%. Sodium periodate can be used as oxidizing agent in order to 
create the aldehyde function which further crosslinks through ADH to form the hydrogel [31]. 
The oxidizing reaction was stopped by adding an equimolar amount of diethyleneglycol to 
reduce any unreacted periodate. The resulting solution was dialyzed for 3 days against 
deionized water using a dialysis membrane with a MW cut off of 1000 Da and then lyophilized 
for 10 days using the freeze-dryer Scanlaf Scanvac 100-9 Pro Alpha 2-4. 
 
3.1.2 – Hyaluronic acid preparation 
Aqueous solutions of the different types of HA (1% w/v) were prepared and an equimolar 
amount of sodium m-periodate was added at room temperature, in the dark and with stirring 
for 24h to oxidize the solution, in order to obtain a theoretical DO of 100%. The oxidizing 
reaction was stopped by adding an equimolar amount of diethyleneglycol. The resulting 
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solution was dialyzed for 3 days against deionized water using a dialysis membrane with a MW 
cut off of 12000-13000 Da for CL-HA and for high MW HA or a dialysis membrane with a MW 
cut off of 1000 Da for low MW HA, and then lyophilized for 10 days using the freeze-dryer 
Scanlaf Scanvac 100-9 Pro Alpha 2-4.  
 
3.1.3 – Preparation of oxidized hyaluronic acid-oxidized dextrin-ADH hydrogels 
Hydrogels of oxidized Dex and oxidized HA were prepared as described in Molinos et al. 
[28] using different proportions: 100% Dex, 70% Dex - 30% HA, 50% Dex - 50% HA, 30% Dex - 
70% HA, and 100% HA. Basically, oxidized HA and oxidized Dex were dissolved in PBS (30% 
w/v) buffer overnight at room temperature. Previously prepared ADH solution in PBS (3.76% 
w/v) was added to crosslink the solution in a 7:3 ratio (material:ADH). For the degradation 
assay, the solution was placed in a Teflon mould and allowed to gel and crosslink for 1h in a 
foam box with humid paper so the hydrogels would not dry during that time. For the other 
assays, the solution was allowed to gel in eppendorfs. 
 
3.2 – Determination of the degree of oxidation by 1H NMR 
Analysis 
 
The DO of oxidized Dex and oxidized HA was quantified using ethylcarbazate (ETC) [41]. 
The samples - Dex, oxidized Dex, CL-HA, oxidized CL-HA - were dissolved in PBS to obtain a 
solution of 1% w/v each. In this preliminary assay, CL-HA was previously oxidized with a 
theoretical DO of 40%. ETC was added to the oxidized samples in a stoichiometric ratio of 5:1 
(ETC:material). After dialysis for 3 days and lyophilisation of the material, the 1H NMR 
spectra were recorded in D2O and used to determine the DO. This is calculated as a peak area 
ratio in the NMR spectra according to Equation 3.1 where X is the average integral 
corresponding to the peak at δ 7.3 for Dex and for CL-HA and Y is the average integral of the 
anomeric protons at δ 5.4 for Dex or δ 2.0 for CL-HA. 
 
DO	(%) =

	
× 100  (3.1) 
 
3.3 – Degradation Assay 
 
After being prepared and weighted (Wi), 500μl hydrogels with different proportions and 
from different types of HA (CL-HA, high MW, and low MW) were immersed in PBS (pH 7.4) and 
incubated at 37ºC. For each condition, samples in triplicate were analyzed, except after day 
5 using CL-HA where only one sample was used. At regular intervals, the hydrogels were 
removed from the solution, blotted with filter paper to remove the excess of PBS, weighted 
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(Wt) and returned to the same container. The buffer solution was replaced at each 
measurement and the percentage of mass loss can be determined by Equation 3.2. 
 
Mass	loss	(%) = 100 −  × 100  (3.2) 
 
3.4 – Cell Culture and Seeding 
 
MG-63 osteoblast-like cells, originally isolated from a human osteosarcoma [21], were 
used for this experiment. MG-63 cells have been well characterized and widely used for 
testing biomaterials. These cells were seeded in 100μl 50:50 Dex:CL-HA hydrogels and in 100% 
CL-HA hydrogels and maintained in α-MEM medium supplemented with 10% fetal bovine serum 
(FBS), 1% ascorbic acid, 1% Fungisoma and 1% Penicilin at 37ºC in the presence of 5% CO2. 
Cells were seeded at a density of 5x104 cells/well in the hydrogels after tripsinization at 
passage 10. Cl-HA and Dex were previously sterilized by ethylene oxide and rest for more 
than 20 days before use. 
After analysing the obtained preliminary results, a second cell culture was performed 
using only 50:50 Dex:CL-HA (n=2), 100% CL-HA (n=2) and 100% Dex (n=3) hydrogels. The 
hydrogels were maintained in 37ºC at 5% CO2 with complete α-MEM medium for 1h to remove 
any traces of non-linked ADH so that it would not acidify the medium and decrease cell 
viability. Since a change in colour was observed, the medium was removed and substituted 
with fresh one in the same conditions, for 30 minutes. After that time, the medium was 
removed and cells were seeded at a density of 3.5x104 cells/well in the hydrogels (passage 
11). 
 
3.5 – Resazurin Viability Assay 
 
Viablity was quantified by performing a resazurin assay one, two, five and seven days 
after seeding MG-63 cells in 50:50 Dex:CL-HA and 100% CL-HA hydrogels. Viability in 100% Dex 
hydrogels was also quantified by performing a resazurin assay 5h after seeding MG-63 cells. 
The medium was removed from the wells and 1ml of resazurin solution (10%) was added in 
the dark. The samples were incubated for 3h and then transferred to a 96-well plate to read 
the fluorescence in a Power Wave XS2 spectrophotometer (Biotek) at 530 nm excitation 
wavelength and 590 nm emission wavelength. 
 
3.6 – MTT Assay 
 
Viability was also analyzed by performing an MTT assay two days after seeding the cells 
in the hydrogels (50:50 Dex:CL-HA (n=2) and 100% CL-HA (n=2)). The medium was removed 
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from the wells and PBS was added to remove any dead cells and cell debris. MTT solution 
(10%) was added in each well and samples were incubated for 2h30 at 37ºC, 5% CO2. The 
supernatant was discarded and 1ml of DMSO was added to dissolve the formazan crystals. 
100μl of the supernatant was transferred to a 96-well plate to read the optical density at 
550 nm in a Power Wave XS2 spectrophotometer (Biotek). 
 
3.7 – Histocompatibility Assays 
 
Oxidized CL-HA and oxidized Dex were previously sterilized by ethylene oxide and rest 
for 10 days before use. 100μl hydrogels were surgically implanted subcutaneously in the 
lumbar region of three male rats (Sasco Sprague Dawley, Barcelona, Spain, weighting around 
300 g), each one receiving three implants of 50:50 Dex:CL-HA hydrogels and two of 100% CL-
HA hydrogels. Previous experimental work already evaluated the biological response of the 
rats using 100% Dex hydrogels as well as a control with no implant but where the suture was 
performed (Sham group). Two animals were housed per cage (Makrolon type 4, Tecniplast, 
VA, Italy), in a temperature and humidity controlled room with 12-12h light/dark cycles, and 
were allowed normal cage activities under standard laboratory conditions. The animals were 
fed with standard chow and water ad libitum. Adequate measures were taken to minimize 
pain and discomfort taking into account human endpoints for animal suffering and distress. 
All procedures were performed with the approval of the Veterinarian Authorities of Portugal, 
and in accordance with the European Communities Council Directive of November 24th 1986 
(86/609/EEC). Anaesthesia was achieved with an intraperitoneal injection of a pre-mixed 
solution consisting in ketamine (Imalgène 1000®), 100 mg/kg body weight, and xylazyne 
(Rompun®), 200 mg/kg body weight. Hair from the dorsal area was clipped and the skin 
scrubbed in a routine fashion with an iodopovodone 10% solution (Betadine®). Five 1.5-2cm 
long linear incisions were performed. After blunt dissection towards the ventral aspect of the 
body, the two types of biomaterial were implanted subcutaneously. Skin and subcutaneous 
tissues were closed with a simple-interrupted suture of a non-absorbable filament 
(Synthofil®, Ethicon). The macroscopic aspect of the wound and the absence of inflammation 
and/or infection were clinically checked by a veterinary before the surgical extraction of the 
implants and surrounding tissues. On days 3, 7 and 14, one animal was randomly selected; 
after performing the same anaesthetic protocol, skin and subcutaneous tissues from the 
implant area were collected and fixed in a container with 10% neutral buffered formalin 
(Panreac, Portugal) for posterior histological evaluation using ISO score as previously 
described. The rats were then euthanized, by lethal intracardiac injection of 5% sodium 
pentobarbital (Euthasil®). Samples were routinely processed, and 5 μm-thin sequential 
sections were stained with hematoxilin-eosin (HE). Slides were examined under a light 
microscope (Nikon E600), and photographs were obtained using a digital camera (Nikon DS-
5M).  
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Chapter 4 
 
Results and Discussion 
4.1 – Production of hyaluronic acid and dextrin hydrogels 
 
4.1.1 – Preparation of the material 
Lyophilisation of oxidized Dex and oxidized HA had an efficiency of 89.8% and 89.3%, 
respectively. Dex, CL-HA and high MW HA appeared white and fluffy after oxidation and 
lyophilisation. However, due to a problem during the lyophilisation of low MW HA, it started 
to hydrate after a few days which means a second lyophilisation of this material was 
necessary. This resulted in a brittle and fragile material. In addition, it appeared a little 
more yellow than CL-HA and high MW HA. 
 
4.1.2 – Different testing conditions 
There are several parameters to be considered when designing hydrogels including 
concentration and source, nature of the crosslinking agent, proportion of the crosslinking 
agent versus polymer, among others. 
HA fragments have highly wide-ranging and often opposing biological functions. Large HA 
polymers are space-filing, anti-angiogenic, immunosuppressive, and prevent differentiation 
maybe due to the suppression of cell-cell interactions or ligand access to cell surface 
receptors. However, smaller HA fragments are inflammatory, immune-stimulatory and 
angiogenic, and compete with large HA polymers for receptors [42]. Various fragments trigger 
different signal transduction pathways. High MW HA can function as a lubrificant, shock 
absorber and as a space-occupying material as in WJ where it may suppress compression of 
the umbilical cord. This type of HA is highly involved in the processes of ovulation, 
fertilization and embryogenesis, also inhibiting phagocytosis by monocytes and macrophages. 
4 Results and Discussion 
26 
 
In addition, high MW HA promotes cell cycle arrest, protects cells against injury and 
maintains epithelial cell integrity. [42
been covalently linked by chemical processing which results in macroscopic HA hydrogel 
materials with viscoelastic properties that are not characte
[43]. This way, in order to check the effect of HA with different
HA were tested: CL-HA, high MW HA and low MW HA.
As explained before, HA may have the ability to delay the differentiation of MSCs. 
However, functionalization of the material regarding degradation rate is also important for 
future applications so different proportions of Dex and HA were used to analyse the different 
properties of the resulting hydrogels. Dex hydrogels have fast degradation, with 100% mass 
loss in 24h in vitro. However, for the here defined goal, the hydrogel sh
before complete degradation so different proportions of Dex and HA were tested to help 
choosing the hydrogel with lowest degradation rate.
Due to the different properties of the resulting hydrogels, they appear with different 
colours. Regarding the hydrogels produced with low MW HA, they become orange coloured 
with the increase of HA percentage, as it can be seen in Figure 4.1, maybe due to the second 
lyophilisation step. However, there is no major difference in colour between the hydro
produced with high MW HA (Figure 4.2) or CL
appeared transparent, similar in colour to hydrogels without HA (Figure 4.3).
 
Figure 4.1. Dex and low MW HA hydrogels with different proportions in 
Figure 4.2. Dex and high MW HA hydrogels with different proportions in the moulds.
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4.1.3 – Gelation time 
The gelation time of the hydrogels can be seen in Table 4.1. Dex and HA were dissolved in 
eppendorfs before adding the crosslinker ADH. Since high MW HA and CL
hygroscopic and have viscous properties [44
which resulted in hydrogels (or highly viscous solutions) of Dex and HA still inside the 
eppendorfs before the addition of ADH. In other hand, due to the high solubility of low MW 
HA, the material Dex plus low MW HA was still liquid. Despite becoming a ge
crosslinker, ADH was still added to each solution in the referred proportions and the material 
was transferred to Teflon moulds. According to Aurande 
with more than 1% HA polymerize very quickly, within 
with this finding. 
In addition, a lower gelation time was observed with an increase in the percentage of HA. 
Since HA is rather viscous, the solution polymerizes very quickly. However, since low MW HA 
is similar to Dex in MW, the solution is not as viscous as the others and the polymerization 
time increases. 
 
Table 4.1. Gelation times for Dex and HA hydrogels according to each proportion and type of HA.
Type of HA 
70:30 Dex:HA
Low MW HA 
High MW HA 
CL-HA 
 
Regarding 100% Dex hy
fact that Dex has high solubility and is much less viscous than HA. According to Molinos 
[28] and Table 2.1, since the theoretical DO of the 100% Dex hydrogel is 40% and ADH has a 
concentration of 3.76% w/v, the obtained value for gelation period should be more than 
30:70 
Dex:HA  
Production of hyaluronic acid and d
 
 Dex and CL-HA hydrogels with different proportions in the moulds.
], their solubility is lower than that of low MW HA
et al. [29] and Figure 2.11, hydrogels 
less than 30 seconds. Our results agree 
Gelation time of Dex and HA hydrogels
 50:50 Dex:HA 30:70 Dex:HA 
1min 1min < 1min 
< 1min * < 1min * < 1min * 
< 1min * < 1min * < 1min * 
*The material polymerized in the eppendorfs before the addition of ADH. 
drogels, gelation occurred in 4 min which can be explained by the 
70:30 
Dex:HA  
50:50 
Dex:HA 
100% Dex 
100% HA
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2min. This way, the gelation period obtained for the 100% Dex hydrogel agrees with the 
literature. 
During crosslinking, oxidized HA (Figure 4.4.A) and oxidized Dex (Figure 4.4.B) react with 
ADH (Figure 4.4.C), resulting in the formation of Dex and HA hydrogels, and of its 
copolymers. 
 
        
Figure 4.4. Basic chemical structure of oxidized Dex (A), oxidized HA (B) and ADH (C). 
 
4.2 – Determination of the degree of oxidation by 1H NMR 
Analysis 
 
Determination of aldehyde groups allows the quantification of the DO of Dex and CL-HA. 
In this assay, the carbazates react with aldehyde groups to form carbazones [45]. The 
chemical shifts are represented in parts per million (ppm). The analysis of Dex and CL-HA will 
be performed based on Figures 4.5 and 4.6, respectively, and Table 4.2 and 4.3. 
 
 
Figure 4.5. Chemical structure of Dex with notation in which 1H NMR analysis is based. 
 
 
Figure 4.6. Chemical structure of HA with notation in which 1H NMR analysis is based. 
B A C 
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Table 4.2. Chemical shift and its structural correspondence for 1H NMR for Dex [28]. 
Chemical shift (ppm) Structural correspondence 
δ = 3.4 - 4.0 C2, C3, C4, C5, C6 
δ = 5.4 Glucose anomeric proton corresponding to α-1,6 linkage 
δ = 7.2 - 7.4 Proton attached to the carbon with linked ETC 
 
Table 4.3. Chemical shift and its structural correspondence for 1H NMR for HA [46]. 
Chemical shift (ppm) Structural correspondence Chemical shift (ppm) Structural correspondence 
δ = 4.51 G1 δ = 3.92 N2 
δ = 3.40 G2 δ = 3.74 – 3.85 N3, N6, G4, G5 
δ = 3.63 G3 δ = 3.51 – 3.62 N4, N5 
δ = 4.61 N1 δ = 2.07 NCOCH3 
 
In homopolysaccharides such as Dex and HA, the oxidation reaction is characterized by 
the opening of the glucopyranoside rings between C2 and C3 (in Dex) and in G2 and G3 (in 
HA). DO can be easily controlled by the relative quantity of sodium periodate used, yielding 
free aldehyde reactive groups to create covalent linkages with crosslinking agents, cellular 
adhesion binding peptides or specific drugs for targeted controlled delivery systems [28]. Due 
to the highly reactive nature of the formed aldehydes, they are easily attacked by 
neighbouring hydroxyl groups, leading to the formation of hemiacetals. In Dex, only one 
aldehyde per residue might be involved in Dex oxidation, while the second aldehyde can be 
arrested to a stable hemiacetal structure [47]. 
Using Equation 3.1 and the data from Figure 4.7, the experimental DO for oxidized Dex is 
29%, which is, as expected, lower than the theoretical value of 40%. The oxidation reaction in 
Dex has an efficiency of about 74%, in agreement with the literature [48]. This indicates that 
29 in 100 disaccharides of Dex have one ring open for future crosslinking. 
 
By comparing Figure S.3 and S.4 it is possible to see that around the chemical shift of 2 
ppm a peak from CL-HA resulted in two peaks in oxidized CL-HA. This indicates that there 
was a change in the conformation caused by the opening of one of the rings and the gain of 
electrons in G2 and G3. The analysis of Figure 4.8 suggests that CL-HA has a DO below 40%, 
since the peak at 7.3 ppm (which corresponds to the proton attached to the carbon with 
linked ETC) is very small. This does not allow an effective calculation of the DO. Since CL-HA 
has a very low solubility, quantifications of the aldehyde groups become very difficult. In 
previous studies [31] low MW HA was oxidized under conditions corresponding to a theoretical 
value of 100%. The experimental value obtained was 44% [31]. According to this oxidation 
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efficiency, the expected value in the present situation should be around 18%. However, it is 
not possible to infer about the oxidation efficiency in 
assays, HA was oxidized with a theoretical DO of 100%.
Figure 4.7.
Figure 4.8.
these conditions. In the following 
 
 
 1H NMR spectrum of oxidized Dex with ETC. 
 
 1H NMR spectrum of oxidized CL-HA with ETC. 
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4.3 – Degradation Assay 
 
The degradation rate of the resulting hydrogels was analysed to help choosing the better 
ratio of the copolymers. 500 μl hydrogels were produced using different combinations of HA-
Dex. Hydrogel degradation depends on the chemical structure of the polymer backbone and 
can occur by surface or bulk erosion. Surface erosion occurs when the rate of erosion exceeds 
the rate of water permeation into the bulk of the polymer. On the other hand, bulk erosion 
occurs when water molecules permeate into the bulk of the matrix at a faster rate than 
erosion, exhibiting complex degradation and erosion kinetics. In hydrogels produced from 
biodegradable polymers such as Dex and HA, degradation occurs mainly by bulk erosion and it 
is characterized by nonlinear degradation profile and an increasing pore size [28]. 
By observing Figures 4.9 to 4.11, it is possible to see that hydrogels produced with low 
MW HA degrades faster than the others. In this case, low MW HA and Dex mixture seems to 
not to led to a mutual interaction, with a fast degradation being observed. There is no clear 
trend regarding the effect of varying the ratio between the two polymers. Kim et al. [44] 
reported that 10 wt % hydrogels with 10 kDa acrylated HA degraded slowly by hydrolysis, with 
40% mass loss after 45 days, which does not agree with the obtained results. One may 
speculate that the second lyophilisation performed with the low MW HA may have had some 
impact in the observed behaviour. The fast degradation may be due to both polymers having 
high solubility, hence higher water affinity, resulting in faster bulk degradation.  
In some of the hydrogels used in this assay (100% Dex, 70:30 Dex:low MW HA, 100% low MW 
HA, 100% high MW HA, 70:30 Dex:CL-HA and 100% CL-HA), the initial phase of the mass loss 
curve bears increased weight, which represents the occurrence of swelling. This is very 
important for cell survival since nutrients must be able to penetrate into the hydrogel. This 
way, their ability to absorb water is highly important [49][50]. Since Dex and HA are 
hydrophilic, it would be expected to see the initial swelling phase for 100% Dex and 100% HA 
hydrogels, an effect also related to osmotic pressure. Since 100% Dex hydrogels have a higher 
swelling, one may hypothesize that Dex is a) more hydrophilic than HA, b) the Dex hydrogel is 
more porous or, c) it presents higher osmotic forces (this is quite likely, since Dex has a much 
lower MW than HA), explaining the higher degradation rate. During degradation, initially a 
small number of crosslinked bonds are broken which do not compromise the whole hydrogel 
network but instead increases its lattice size, resulting in a large water absorbance and 
further hydrolysis. This results in a faster degradation, as seen in the referred hydrogels. 
After the broken crosslinked bonds reached a critical value, the crosslinking network 
dissociates and mass loss is observed. 
Analysing Figures 4.9 to 4.11 it is possible to conclude that the weight loss increases with 
the Dex contents, suggesting that the degradation is depending on the 
dissociation/dissolution of Dex from the hydrogels. Since Dex and HA have a high water-
binding capacity, they should be dissolved quickly in water as the hydrazone bonds undergo 
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hydrolysis. Further trials must be performed to confirm the observed trend of a lower 
degradation of the 100% HA hydrogel, followed by a rather fast degradation. The mixed 
hydrogels apparently bear a steady rate of mass loss. Su et al. [31] reported that 6%wt 
oxidized HA (with a MW of 320 kDa) hydrogels crosslinked with 4% ADH degraded after 12 
days. The obtained results for 100% high MW HA and 100% CL-HA hydrogels agree with these 
results despite the difference in MW and polymer concentration. In the same report [31], 
hydrogels in the same conditions but crosslinked with 2% ADH degraded in three days which 
implies that a lower concentration of the crosslink agent increases the degradation rate. Due 
to the high viscosity of the material, its crosslinking is difficult and influences the 
degradation rate. 
In each hydrogel, the degradation rate slows down after a few days since the cleavage of 
hydrazone bonds by water has reached a critical value. It is also possible to see that 
hydrogels produced with high MW HA or CL-HA have a better degradation rate. In this 
situation, the proportions with the lowest degradation rate are 50:50 and 30:70 Dex:HA which 
suggests that the interaction between Dex and HA delay degradation maybe due to the three 
dimensional lattice that retains the degraded material inside. Throughout degradation, it is 
possible to see that hydrogels with high MW HA or CL-HA change colour from transparent to 
orange which implies that HA chains are being released since hydrogels appear with the same 
colour as low MW hydrogels. 
 
It is possible to conclude that the degradation rate can be tuned and controlled by 
altering the material proportions or/and its concentration. 
 
 
 
Figure 4.9. Degradation profile of Dex and low MW HA hydrogels (n=3) in PBS. 
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Figure 4.10. Degradation profile of Dex and high MW HA hydrogels (n=3) in PBS. 
 
 
 
Figure 4.11. Degradation profile of Dex and CL-HA hydrogels (n=3 until day 5, n=1 after day 5) in PBS. 
 
 
4.4 – Resazurin Viability Assay 
 
A resazurin assay was performed to evaluate cellular viability in the hydrogels. Due to the 
lack of material only 50:50 Dex:HA and 100% HA hydrogels were used in this assay. One day 
after seeding, it was observed that the medium with hydrogels became orange, comparing 
with the pink control medium (Figure 4.12). This indicates that the medium was turning acid, 
which is likely due to non-linked ADH. The pH observed (7.0) is normally not dangerous 
enough for the cells, which optimally require pH 7.4. This loss of viability in vitro in 
absorbable materials is quite frequent due to the change of pH. However, when working in 
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closed systems, as the in vitro assays performed in this work, the dilution effects does not 
occur whereas the constant change of fluids in vivo, prevent the accumulation of degradation 
products at high concentrations [29]. A classic example of this fact is gluteraldehyde, which 
is a widely used cross-linker, often considered cytotoxic in vitro, even at low concentrations 
[52][53]. However, it is still used for reticulation of biomedical products [54]. A resazurin 
assay was still performed for days 1, 2 and 5 after seeding (Figure 4.13) and 
microphotographs were taken (Figure 4.14).  
 
 
Figure 4.12. Macroscopic analysis of the hydrogels and MG-63 cells one day after seeding. 
 
 
Figure 4.13. Relative intensity of the hydrogels with MG-63 cells (n=3), hydrogels without MG-63 cells (n=1) and 
the cellular control (n=1) using fluorescence at 530 nm excitation wavelength and 590 nm emission wavelength. 
 
 
Probably due to the acid medium previously explained, MG-63 cells in the hydrogels 
started to die and bear a round shaped morphology, as seen in Figure 4.14. However, since 
there was no influence of the hydrogel in the cellular control, MG-63 cells presented 
increased viability with time. In addition, samples with only hydrogels and without cells also 
appeared with high viability for day 1 which may suggest that Dex and HA interfere with 
resazurin, occurring false positive results. 
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Figure 4.14. Microscopic analysis of the hydrogels and cells one, two and five
(amplification: 40x). 
 
A second cell culture was performed with a different method. Before cell seeding
hydrogels were maintained in α
was included to remove non
performed for days 1, 2, 5 and 7 after seeding. Figures 4.15 and 4.16 show that metabolically 
active MG-63 cells were present in 100% HA hydrogels and in the cellular control. In these 
hydrogels cells appeared elongated, with increasing viability over time. However in 50:50 
Dex:HA hydrogels the number of metabolically active MG
presented a round shaped morphology.
Dex hydrogels through a live and dead assay were assessed. In this study, mouse embryo 3T3 
fibroblasts were encapsulated in oxidized Dex hydrogels and live and dead fluorescence was 
analysed after 6h of incubation, the exactly time point when the hydrogel when
begins. Results indicated that t
dex hydrogel (98.2±1.9%) were calcein positive
cross-linking stage, thus becom
used for tissue engineering purposes.
fact the hyaluronic acid is a much more viscous material, even in solution, a fact that 
difficults the homogenization of the so
components will probably cause a great amount of non
result in a higher degree of cytotoxicity. 
Resazur
-63 cells 
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MG
  
  
  
-MEM medium until there was no change in colour. This step 
-linked ADH that could damage the cells. This resazurin assay was 
-63 cells was very low and cells 
 In a previous work (data not shown) cell viability in 
he majority of the cells that were kept encapsulated in the 
 (viable) cells and that cells could endure the 
ing a suitable platform for the incorporation of cells to be 
 Another explanation for this behaviour was due to the 
lutions of Dex/HA with ADH. A poorly mixture of these 
-linked aldehyde groups, which can 
In addition, non-linked ADH could be present inside 
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the hydrogel and being released throughout time due to degradation. Figure 4.18 also shows 
that the viability assay using resazurin presents high intensity in the samples without cells, 
which can indicate false positive results
 
 
50:50 Dex:HA hydrogels 
with MG-63 cells
Day 1 
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Figure 4.15. Microscopic analysis of the hydrogels and cells one, two, five and seven days after seeding and 
treatment of the hydrogels (amplification:
 
A viability assay using resazurin was also performed in 100% Dex hydrogels. Since these 
hydrogels have a high degradation rate, viability was measured 5h after their production. 
Results (Figure 4.17) suggest
the control. These results are consistent with previous works showing high viability obtained 
by live and dead assays and also with the subcutaneous implants performed with Dex 
hydrogels incorporating human mesenchymal steam cells
revealed the presence of these cells in the soft tissue surrounding the implant site. 
may not be enough for cell adhesion to occur. Due to the processes involved in this 
measurement, there could be a decrea
removed and substituted by the resazurin solution. This way, this test may reveal more about 
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cell adhesion than viability, indicating a higher cell adhesion in the hydrogels than in the 
control. A 3D matrix mimics better the microenvironment than 2D models. Chen et al. [51] 
analysed the effect of 3D and 2D cell cultures using osteosarcoma cells and observed that 3D 
fibrous culture had better cell growth and higher metabolic rates than 2D cultures since in a 
3D environment cells are protected from shear stress. In addition, Chang et al. [55] studied 
the behaviour of MSCs in a 3D matrix and results showed better adhesion and growth rate in 
the 3D matrix than in the 2D culture. In a 3D matrix MSCs showed colocalization of α5 integrin 
and αv integrin which increased cell adhesion due to focal adhesions. [55] This may explain 
the higher values obtained for the cells in the hydrogel than in the control. Due to a 
malfunction in the equipment, it was not possible to obtain microphotographs of the cells. 
 
 
Figure 4.16. Relative intensity of the hydrogels with MG-63 cells (n=2), hydrogels without MG-63 cells (n=1) and 
the cellular control (n=2) one, two, five and seven days after seeding and treatment of the hydrogels using 
fluorescence at 530 nm excitation wavelength and 590 nm emission wavelength. 
 
 
Figure 4.17. Relative intensity of the hydrogels with MG-63 cells (n=3), hydrogels without the MG-63 cells (n=2) 
and the cellular control (n=2) using fluorescence at 530 nm excitation wavelength and 590 nm emission wavelength 
5h after the production of 100% Dex hydrogels. 
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4.5 – MTT Assay 
 
Metabolically active and viable cells produce mitochondrial dehydrogenase enzymes 
during incubation in media, which is usually catalyzed by MTT salt. This reaction produces 
purple colored formazan which allows for the quantification of cell viability by measuring 
the change in colour intensity using a spectrophometer. An initial analysis was performed 
using an MTT assay after 2 days of incubation and results can be seen in Figures 4.18 and 
4.19. In metabolically active cells, star-shaped morphology is observed due to the MTT 
colouring. Results indicate that, although the majority of the cells in the hydrogels appear 
dying and bear a round shaped morphology, the absorbance values indicate higher cell 
viability in the hydrogels with the cells than in the control of only MG-63 cells. This data 
does not agree with the results obtained from the resazurin assay (Figure 4.14) and from 
the visual analysis of Figure 4.18. Although some metabolically active cells with star-shaped 
morphology are present in the samples, it is not sufficient to result in higher values of 
absorbance than those from control. Moreover, samples with no cells implanted (50:50 
Dex:HA and 100% HA hydrogels) also appeared with high values of absorbance which suggest 
that false positive results occur in the MTT assay and that Dex and HA interfere with MTT.  
 
50:50 Dex:HA 
hydrogels with 
MG-63 cells 
 
100% HA 
hydrogels with 
MG-63 cells 
 
MG-63 cells 
(control) 
 
Figure 4.18. Microscopic photographs of the different hydrogels and the cellular control before the addition of 
DMSO to dissolve MTT. It is possible to observe metabolically active cells in the hydrogels (arrow) and in the control 
(amplification: 40x). 
 
MTT Assay 4.5 
39 
 
 
Figure 4.19. Relative absorbance for the hydrogels with MG-63 cells (n=3), hydrogels without MG-63 cells (n=1) 
and the cellular control (n=1). 
 
 
4.6 – Histocompatibility Assays 
 
A biocompatibility analysis should be performed to verify if a material can be used in 
vivo. The FDA relies on ISO 10993 Standard to test biocompatibility and cytotoxicity of a 
material and the analysis can be performed using histological samples of the tissues where 
the biomaterial was implanted. Due to the low gelation time, it is not possible to inject the 
material in in vivo applications so the hydrogels must be produced in eppendorfs and then 
placed subcutaneously in the lumbar region of rats. Evaluation was performed at 3, 7 and 14 
days after implantation for 50:50 Dex:CL-HA (n=3) and 100% CL-HA (n=2) hydrogels. Data from 
previous reports using 100% Dex hydrogels was used. Figure 4.20 shows the macroscopic 
analysis of the necropsy of the mice where the hydrogels were implanted. No macroscopic 
signs of inflammation, cytotoxicity or fibrosis were found. 
When a material is implanted in the body, several processes occur including injury, 
blood-material interactions, provisional matrix formation, acute inflammation, chronic 
inflammation, granulation tissue development, foreign body reaction, and fibrosis or fibrous 
capsule development [56]. The extent or degree of the inflammatory reactions is controlled 
by the extent of injury in the implantation procedure, the tissue into which the biomaterial is 
implanted, and the extent of the provisional matrix formation. Each stage is characterized by 
different cell types, as seen in Figure 4.21. Acute inflammatory response is characterized by 
neutrophils (polymorphonuclear leukocytes) and is mediated by mast cell degranulation with 
histamine release and fibrinogen adsorption. On the other hand, chronic inflammation is 
identified by the presence of mononuclear cells, such as monocytes, lymphocytes and plasma 
cells, at the implant site [57]. Chronic inflammation has been also used to describe the 
foreign body reaction where monocytes, macrophages, and foreign body giant cells are 
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present at the biomaterial interface. The persistence of inflammatory responses beyond a 
three-week period usually indicates an infection. Using biocompatible materials, chronic 
inflammatory response usually lasts no longer than two weeks. Following resolution of these 
phenomena, the formation of granulation tissue is identified by the presence of macrophages, 
the infiltration of fibroblasts, and neovascularisation in the new healing tissue. In the foreign 
body reaction, there is a release of cytokines that stimulate inflammation and fibrosis. This 
response is characterized by multinucleated giant cells that result from fusion of 
macrophages [56].  
Hydrogels have advantages in biocompatibility. Their swelling capacity allows the 
expulsion of impurities, decreasing the inflammatory responses. In addition, hydrogels 
decrease the frictional and mechanical irritation of the tissues [58]. 
 
 
 50:50 Dex:HA 100% HA 100% Dex 
Day 3 
 
Day 7 
No previous evaluation was 
performed at 7 days after 
implantation of 100% Dex 
hydrogels. 
Day 
14 
 
Figure 4.20. Macroscopic analysis of the subcutaneously implantation of Dex and HA hydrogels in the lumbar 
region of the rats. 
 
 
Histocompatibility Assays 4.6 
41 
 
 
 
 
Figure 4.21. Relative intensity of different cell levels during inflammatory response [57]. 
 
 
In histological analysis, quantitative scoring is given for each histological characteristic 
evaluated, such as capsule formation, inflammation and presence of giant cells, comparing 
the tissue in analysis with the negative control sample. The quantitative score is based on 
Tables 4.4 and 4.5 and this evaluation system can be converted to an implant evaluation 
system as described in Table 4.6. Control sample corresponds to the inflammatory response 
of the surgery. Under the conditions observed and the obtained score, the test sample can be 
considered non-irritant (0.0 up to 2.9), slight irritant (3.0 up to 8.9), moderate irritant (9.0 
up to 15.0) or severe irritant (over 15.0) [59]. 
 
 
 
Table 4.4. Histological evaluation system based on cell type/response. phf stands for per high powered (400x) field 
[59]. 
Cell type/response 
Score 
0 1 2 3 4 
Polymorphonuclear cells 0 Rare, 1-5/phf 5-10/phf Heavy infiltrate Packed 
Lymphocytes 0 Rare, 1-5/phf 5-10/phf Heavy infiltrate Packed 
Plasma cells 0 Rare, 1-5/phf 5-10/phf Heavy infiltrate Packed 
Macrophages 0 Rare, 1-5/phf 5-10/phf Heavy infiltrate Packed 
Giant cells 0 Rare, 1-2/phf 3-5/phf Heavy infiltrate Sheets 
Necrosis 0 Minimal Mild Moderate Severe 
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Table 4.5. Histological evaluation based on tissue response [59]. 
Tissue response 
Score 
0 1 2 3 4 
Neovascularisation 0 
Minimal 
capillary 
proliferation, 
focal, 1-3 
buds 
Groups of 4-7 
capillaries with 
supporting 
fibroblastic 
structures 
Broad band of 
capillaries with 
supporting 
structures 
Extensive band of 
capillaries with 
supporting fibroblastic 
structures 
Fibrosis 0 Narrow band 
Moderately 
thick band 
Thick band Extensive band 
Fatty infiltrate 0 
Minimal 
amount of fat 
associated 
with fibrosis 
Several layers of 
fat and fibrosis 
Elongated and broad 
accumulation of fat 
cells about the 
implant site 
Extensive fat 
completely 
surrounding the 
implant 
 
Table 4.6. Semi-quantitative evaluation system. 
a
 Used to determine irritant ranking. A negative difference is 
recorded as zero [59]. 
Test sample: 
Implantation interval: 
Test sample Control sample 
Inflammation 
Polymorphonuclear cells 
      
Lymphocytes       
Plasma cells       
Macrophages       
Giant cells       
Necrosis       
SUB-TOTAL (X2)       
Neovascularisation       
Fibrosis       
Fatty infiltrate       
SUB-TOTAL       
TOTAL       
GROUP TOTAL       
AVERAGE 
a
 TEST (-) CONTROL = 
Traumatic necrosis       
Foreign debris       
No. sites examined       
 
 Evaluation was performed using the Sham group (control with no implant but where the 
suture was performed) with the quantitative score of 15.33, 15.33 and 14.11 for 3, 7 and 14 
days of implantation, respectively. After performing this evaluation, results (Table 4.7) 
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indicate that 50:50 Dex:HA hydrogels were slight irritant during the 14 days period. On the 
other hand, 100% HA hydrogels were non-irritant 3 days after implantation and slight irritant 
after that time. In contrast, 100% Dex hydrogels were slight irritant 3 days after implantation 
and non-irritant after 14 days. Since 100% Dex hydrogels have a high degradation rate, after 
14 days the hydrogel was already degraded, decreasing the inflammatory response and 
evaluating the hydrogel as non-irritant. However, due to the lower degradation rate 100% HA 
and 50:50 Dex:HA hydrogels were still present, causing an inflammatory response. As long as 
the hydrogel is not degraded, an inflammatory reaction will occur. 
 
Table 4.7.Quantitative scoring of histocompatibility for 50:50 Dex:HA, 100% HA and 100% Dex hydrogels for 
3, 7 and 14 days after implantation. 
 
3 days 7 days 14 days 
50:50 Dex:HA hydrogel 
6.3 (slight irritant) 7.2 (slight irritant) 8.9 (slight irritant) 
100% HA Hydrogel 
2.0 (non-irritant) 8.0 (slight irritant) 6.4 (slight irritant) 
100% Dex Hydrogel 
4.1 (slight irritant) - 2.1 (non-irritant) 
 
Three days after the implantation of 50:50 Dex:HA hydrogels (Figure 4.22) it is possible 
to observe high levels of neutrophils, lymphocytes and active macrophages. Mild necrosis is 
also present. After 7 days of implantation (Figure 4.23), the number of neutrophils 
decreased, as well as necrosis. Giant cells were present associated with foreign body reaction 
caused, for instance by hair and probably increasing the inflammatory levels. In addition, 
fibrosis slightly increased. Mild oedema was also present. At 14 days after implantation 
(Figure 4.24), the number of active macrophages decreased and the number of giant cells 
increased. The latter were strongly associated with foreign bodies probably increasing the 
final score. At this point, neovascularisation and fibrosis also increased. 
 
 
Figure 4.22. Histological analysis of the subcutaneously implantation of 50:50 Dex:HA hydrogels in the lumbar 
region of the rats after 3 days  where is possible to observe necrosis (N), neutrophils (PMN), lymphocytes (L) and 
macrophages (M) (HE, amplification: 200x). 
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Figure 4.23. Histological analysis of the subcutaneously implantation of 50:50 Dex:HA hydrogels in the lumbar 
region of the rats after 7 days  where is possible to observe the implantation site (arrow), blood vessels (BV) and 
foreign bodies (FB) (HE, amplification: 40x). 
 
 
 
Figure 4.24. Histological analysis of the subcutaneously implantation of 50:50 Dex:HA hydrogels in the lumbar 
region of the rats after 14 days  where is possible to observe the incision site (I), blood vessels (BV) and foreign 
bodies (FB) (HE, amplification: 20x). 
 
 
Regarding 100% HA hydrogels, after 3 days of implantation high levels of neutrophils and 
macrophages were present, suggestive of a subacute inflammatory response. In addition, mild 
neovascularisation was observed and few lymphocytes and plasma cells were found, which 
accounts for the low quantitative score. After 7 days of implantation (Figure 4.25), giant cells 
were found as well as an increased number of lymphocytes. More neovascularisation and mild 
BV 
FB 
I 
FB 
BV 
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fibrosis were also observed and a thick fibrotic capsule surrounding the implantation site was 
present. At 14 days after implantation (Figures 4.26 and 4.27) it was still possible to observe 
few traces of hydrogel. At this point, no necrosis nor neutrophils were found. Lymphocytes 
levels were increased and minimal fibrosis was observed. In contrast with other hydrogels, 
fatty infiltrate was found. 
 
 
 
Figure 4.25. Histological analysis of the subcutaneously implantation of 100% HA hydrogels in the lumbar 
region of the rats after 7 days where is possible to observe the implantation site (arrow) and blood vessels (BV) (HE, 
amplification: 40x). 
 
 
 
Figure 4.26. Histological analysis of the subcutaneously implantation of 100% HA hydrogels in the lumbar 
region of the rats after 14 days where is possible to observe a few tracesof the hydrogel (arrows) and blood vessels 
(BV) (HE, amplification: 400x). 
 
BV 
BV 
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Figure 4.27. Histological analysis of the subcutaneously implantation of 100% HA hydrogels in the lumbar 
region of the rats after 14 days where is possible to observe fatty infiltrate (HE, amplification: 200x). 
 
 
100% Dex hydrogels caused fibrinoid necrosis after 3 days of implantation (Figure 4.28). 
High levels of neutrophils, lymphocytes, macrophages and neovascularisation were present in 
this inflammatory reaction which indicates the transition between acute to chronic 
inflammations. At 14 days of implantation (Figure 4.29) higher levels of fibrosis and 
neovascularisation were present but there was a decrease in neutrophils levels and necrosis 
which is compatible with tissue formation.   
 
 
 
Figure 4.28. Histological analysis of the subcutaneously implantation of 100% Dex hydrogels in the lumbar 
region of the rats after 3 days. It is possible to observe the implantation site (arrow) (HE, amplification: 40x). 
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Figure 4.29. Histological analysis of the subcutaneously implantation of 100% Dex hydrogels in the lumbar 
region of the rats after 14 days. It is possible to observe the implantation site (arrow) (HE, amplification: 40x). 
 
Although the higher quantitative scoring of 50:50 Dex:HA hydrogels compared to the 
ones obtained with 100% HA and 100% Dex hydrogels, no fibrous capsule or fatty infiltrate was 
present in the inflammatory reaction which can suggest that mixed hydrogels have an 
appropriate histocompatibility. 
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Chapter 5 
 
Conclusions 
Due to their different properties, several types of HA were tested with Dex using 
different proportions. The production of the hydrogels revealed that high MW HA and CL-HA 
have low solubility, resulting in highly viscous hydrogels. Consequently, a lower gelation time 
was observed with an increase in the percentage of HA. In addition high MW HA and CL-HA 
hydrogels polymerized in the eppendorf without the crosslinking agent. 
The obtained DO of oxidized Dex was lower than the theoretical value, in agreement 
with the literature. Due to the low solubility of CL-HA, aldehyde groups were very difficult to 
quantify so it was not possible to measure the experimental DO for oxidized CL-HA. 
Degradation assays revealed that 100% Dex hydrogels and low MW HA hydrogels have 
higher degradation rates due to their high solubility and high water affinity. On the other 
hand, hydrogels with higher MW HA and higher HA contents revealed a low degradation rate, 
suggesting that the weight loss increases with the Dex contents. Several factors may 
influence the degradation behaviour besides the MW such as hydrophilicity of the materials, 
porosity and osmotic forces. In some hydrogels a swelling phase was observed which can be 
important for cell survival. Mixed hydrogels bear a steady rate of mass loss in contrast with 
100% HA hydrogels which displayed an initial low degradation rate followed by a rather fast 
degradation. Due to its lower degradation rate, the 50:50 Dex:CL-HA was chosen for the 
following tests.  
Resazurin assays were used to account for cell viability using MG-63 cells during 7 days 
and indicated that in vitro MG-63 cells in 50:50 Dex:HA hydrogels had very low viability in 
comparison with MG-63 cells in 100% HA hydrogels and with the cellular control. This may be 
due to the lattice of 50:50 Dex:HA hydrogels that may enclosure non-linked ADH or due to the 
exposure of free aldehyde groups. Another resazurin assay performed 5h after the production 
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of 100% Dex hydrogels showed higher values for MG-63 cells in the hydrogels than in the 
cellular control which, due to the processes involved, suggest a higher cellular adhesion in 
the hydrogels than in plastic. A MTT assay was also performed and revealed that Dex and HA 
interfere with MTT, presenting false positive results. 
Histocompatibility assays were performed by implanting subcutaneously 50:50 Dex:HA 
and 100% HA hydrogels in the lumbar region of rats. Macroscopic observation of the 
implantation site revealed no necrosis or fibrosis during the 14 days period. Histological 
analysis indicated that 50:50 Dex:HA hydrogels were slight irritant during the 14 days. On the 
other hand, 100% HA hydrogels were non-irritant 3 days after implantation and slight irritant 
after that time. In contrast, 100% Dex hydrogels were slight irritant 3 days after implantation 
and non-irritant after 14 days. This can be explained by differences in the degradation rate. 
 
These tests indicate that a hydrogel produced with Dex and HA has the potential to 
maintain MSCs but further research is necessary to better characterize the hydrogels and its 
biological functions. The DO of HA should be determined using low MH HA due to its high 
solubility. Optimization of the production of the hydrogels should be performed to reduce 
free aldehyde groups, changing either the DO and/or the ADH concentration. Consequently, 
an optimization of the characteristics of the hydrogel should also occur by varying several 
factors including the polymer concentration, the DO and the proportion of Dex and HA. 
Viability tests should be performed using techniques that do not cause false positive results 
and more assays should be performed to validate the obtained results. Due to their different 
biological characteristics, different types of HA should be used in these assays. The negative 
charge of HA provides high water binding capability and water absorption capacity, creating a 
large porous matrix space and promoting cellular migration so a cryo-SEM should be 
performed to study the topography and porosity of the hydrogels. 
While it is possible that osteosarcoma cells represent a suitable model for studying 
osteoblastic differentiation on biomaterials, it is not yet clear that these cells mimic the 
behaviour of MSCs during the initial phases of cell attachment to a biomaterial so further 
testing should be performed using fresh and cryopreserved MSCs for comparison. The duration 
of the undifferentiated state in mixed hydrogels should be tested for long test periods until 
the MSCs in the control differentiate. This characterization can be done using cytogenetic 
analysis, analysis of gene expression by RT-PCR and microbiological assays to test for 
osteogenic or chondrogenic differentiation in different time points. Quantification of ALP 
activity can be used as a marker for osteoblast differentiation. 
  
 Support Material 
Figure S1. 1H NMR spectrum of Dex. 
 
Figure S2. 1H NMR spectrum of oxidized Dex. 
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Figure S3. 1H NMR spectrum of CL-HA. 
 
Figure S4. 1H NMR spectrum of oxidized CL-HA. 
 
 
 
  
 
Figure S5. 1H NMR spectrum of ETC. 
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